Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GS-9674
GS-9674
Gilead’s GS-9674 shows positive action in primary sclerosing cholangitis
Pharmaceutical Business Review
Mon, 11/12/18 - 09:24 am
Gilead Sciences
GS-9674
primary sclerosing cholangitis
clinical trials
Gilead's search for the next great liver drug won't end with its FXR agonist
Biopharma Dive
Sat, 11/10/18 - 12:01 pm
Gilead Sciences
liver disease
GS-9674
Gilead's FXR agonist among NASH therapies highlighted ahead of AASLD
BioCentury
Tue, 10/2/18 - 11:01 pm
Gilead Sciences
NASH
GS-9674
FXR agonists
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
CP Wire
Fri, 04/13/18 - 12:16 pm
Gilead Sciences
NASH
selonsertib
GS-9674
GS-0976
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Fri, 04/13/18 - 12:10 pm
Gilead
NASH
selonsertib
GS-9674
GS-0976
Inside Gilead Sciences’ Active Involvement in Drugs for NASH
Yahoo/Market Realist
Thu, 05/12/16 - 09:44 am
Gilead Sciences
NASH
simtuzumab
GS-4997
GS-9674